Evidence map›Paper›PMID 21784632›Full record

ArticleBioorganic & medicinal chemistry letters2011

New inhibitors of colony spreading in Bacillus subtilis and Bacillus anthracis.

Xin Hao, Tam Nguyen, Daniel B Kearns, Carolynn C Arpin, Ray Fall, Tarek Sammakia

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xin HaoDepartment of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA.
Tam Nguyen
Daniel B Kearns
Carolynn C Arpin
Ray Fall
Tarek Sammakia

Funding

NEW METHODS FOR STEREOSELECTIVE ADDITIONS TO CARBONYLSR01GM048498 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI SAMMAKIA, TAREK · 1993 to 2008
$2.0M
NIGMS NIH HHS GM-48498NIGMS NIH HHS R01 GM048498
6 · The paper itself

Abstract

We have recently characterized sliding motility in Bacillus subtilis strains that lack functional flagella, and here describe the discovery of inhibitors of colony spreading in these strains as well as the aflagellate pathogen, Bacillus anthracis. Aflagellate B. subtilis strains were used to screen for new types of antibacterials that might inhibit colony spreading on semi-solid media. From a diverse set of organic structures, p-nitrophenylglycerol (NPG), an agent used primarily in clinical laboratories to control Proteus swarming, was found to inhibit colony spreading. The four stereoisomers of NPG were synthesized and tested, and only the 1R,2S-(1R-anti) and 1R,2R-(1R-syn) NPG isomers had significant activity in a quantitative colony-spreading assay. Twenty-six NPG analogs and related structures were synthesized and tested to identify more active inhibitors. p-Methylsulfonylphenylglycerol (p-SPG), but not its ortho or meta analogs, was found to be the most effective of these compounds, and synthesis and testing of all four p-SPG stereoisomers showed that the 1R-anti-isomer was the most active with an average IC(50) of 16 μM (3-5 μg mL(-1)). For B. anthracis, the colony-spreading IC(50) values for 1R-anti-SPG and 1R-anti-NPG are 12 μM (2-4 μg mL(-1)) and >150 μM, respectively. For both Bacillus species tested, 1R-anti-SPG inhibits colony spreading of surface cultures on agar plates, but is not bacteriostatic or bacteriocidal in liquid cultures. Work is in progress to find the cellular target(s) of the NPG/SPG class of compounds, since this could lead to an understanding of the mechanism(s) of colony spreading as well as design and development of more potent inhibitors for the control of B. anthracis surface cultures.

Indexed as

Anti-Bacterial AgentsBacillus anthracisBacillus subtilisDose-Response Relationship, DrugDrug DiscoveryGlycerolMicrobial Sensitivity TestsMolecular StructureNitrobenzenesStereoisomerismStructure-Activity RelationshipSulfones4-nitrophenylglycerolAnti-Bacterial AgentsGlycerolNitrobenzenesp-methylsulfonylphenylglycerolSulfones

Identifiers

PMID21784632
PMCPMC3159833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.